Beam Therapeutics (NASDAQ:BEAM) is one of the 17 biotechnology stocks with more than 50% upside. On January 22, Patrick Trucchio from H.C. Wainwright maintained a Buy rating on Beam Therapeutics ...
Beam Therapeutics recently announced that it secured a standby license with Kobe University and Bio Palette for key gene-editing patents and confirmed the upcoming resignation of board member Carole ...
Yeckel] recently put the finishing touches on an ambitious implementation of a simple D-STAR (Digital Smart Technologies for Amateur Radio) transceiver using some very accessible and affordable ...
The motion of neutral molecules in a beam can be manipulated with inhomogeneous electric and magnetic fields. Static fields can be used to deflect or focus molecules, whereas time-varying fields can ...
Bulletin: ...WINTER WEATHER ADVISORY IN EFFECT FROM 1 AM TO 10 AM EST FRIDAY... * WHAT...Mixed precipitation expected. Ice accumulations up to one tenth of an inch ...
There is currently no schedule data. The NFL Schedule will be released in May.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results